Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05645393 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Estradiol Topical Products
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
NCT05645393 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 4 participants.
The verdict
NCT05645393, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The aim of the present study is to determine if two products can deliver bioequivalent amounts of estrogen (estradiol, estriol, and estrone).
Interventions
- DRUG topical estrogen product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2025-03-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05645393
The ClinicalTrials.gov registry entry for NCT05645393 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which topical estrogen product is the first listed.
NCT05645393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05645393 about?
NCT05645393 is a clinical study titled "Effect of Estradiol Topical Products". The aim of the present study is to determine if two products can deliver bioequivalent amounts of estrogen (estradiol, estriol, and estrone).
What is the current status of trial NCT05645393?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2024-06-05. Estimated completion is 2025-03-30.
What interventions are being tested in trial NCT05645393?
The interventions under investigation include: topical estrogen product (DRUG).
Who is sponsoring clinical trial NCT05645393?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.